Research Publications (Food Safety)

Tracing and isolation of close contacts is used to control outbreaks of coronavirus disease 2019 (COVID‐19) in China. However, risk factors associated with occurrence of COVID‐19 among close contacts have not been well described. 106 household contacts were included in this study, of whom 19 were developed into COVID‐19 cases and the secondary attack rate was 17.9%.

International travel may facilitate the spread of the novel coronavirus disease (COVID‐19). The study describes clusters of COVID‐19 cases within Chinese tour groups travelling in Europe January 16–28. We compared characteristics of cases and non‐cases to determine transmission dynamics. The index case travelled from Wuhan, China, to Europe on 16 January 2020, and to Shanghai, China, on 27 January 2020, within a tour group (group A).

Infection with the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS‐CoV‐2) induces the coronavirus infectious disease 19 (COVID‐19). Its pandemic form in human population and its probable animal origin, along with recent case reports in pets, make drivers of emergence crucial in domestic carnivore pets, especially cats, dogs and ferrets. Few data are available in these species; we first listed forty‐six possible drivers of emergence of COVID‐19 in pets, regrouped in eight domains (i.e.

Event‐based surveillance (EBS) systems monitor a broad range of information sources to detect early signals of disease emergence, including new and unknown diseases. In December 2019, a newly identified coronavirus emerged in Wuhan (China), causing a global coronavirus disease (COVID‐19) pandemic. A retrospective study was conducted to evaluate the capacity of three event‐based surveillance (EBS) systems (ProMED, HealthMap and PADI‐web) to detect early COVID‐19 emergence signals.

The world is confronting a dire situation due to the recent pandemic of the novel coronavirus disease (SARS‐CoV‐2) with the mortality rate passed over 470,000. Attaining efficient drugs evolve in parallel to the understanding of the SARS‐CoV‐2 pathogenesis. The current drugs in the pipeline and some plausible drugs are overviewed in this paper.

COVID‐19 pandemic disease spread by the SARS‐COV‐2 single‐strand structure RNA virus, belongs to the 7th generation of the coronavirus family. Following an unusual replication mechanism, it’s extreme ease of transmissivity has put many counties under lockdown. With uncertainty of developing a cure/vaccine for the infection in the near future, the onus currently lies on healthcare infrastructure, policies, government activities, and behaviour of the people to contain the virus.

SARS‐CoV‐2 causes the ongoing COVID‐19 pandemic. ACE2 is the functional receptor for SARS‐CoV‐2. In our current study, we found that two types of deficient ACE2 isoforms from different mammals would compete with full length ACE2 for association with S protein. One type of ACE2 is a natural soluble isoform, the other type of ACE2 only associates with one loop of RBD of SARS‐CoV‐2 S protein. Mammals with either type of ACE2 will be deficient in support of SARS‐CoV‐2 entry.

We investigated an outbreak of COVID‐19 infection, which was traced back to a bathing pool at an entertainment venue, to explore the epidemiology of the outbreak, understand the transmissibility of the virus and analyse the influencing factors. Contact investigation and management were conducted to identify potential cases. Epidemiological investigation was carried out to determine the epidemiological and demographic characteristics of the outbreak.

The SARS‐CoV‐2 coronavirus is responsible for the current COVID‐19 pandemic, with an ongoing toll of over 5 million infections and 333 thousand deaths worldwide within the first 5 months. Insight into the phylodynamics and mutation variants of this virus is vital to understanding the nature of its spread in different climate conditions. The incidence rate of COVID‐19 is increasing at an alarming pace within subtropical South‐East Asian nations with high temperatures and humidity.

Coronavirus (CoV) pandemics have become a huge threat to the public health worldwide in the recent decades. Typically, severe acute respiratory syndrome CoV (SARS‐CoV) caused SARS pandemic in 2003 and SARS‐CoV‐2 caused the ongoing COVID‐19 pandemic. Both viruses are most likely originated from bats. Thus, direct or indirect interspecies transmission from bats to humans is required for the viruses to cause pandemics.

The novel SARS‐CoV‐2 coronavirus has attracted attention due to the high number of human cases around the world. It has been proposed that this virus originated in bats, possibly transmitted to humans by an intermediate host, making bats a group of great interest during this outbreak. Almost 10% of the world's bat species inhabit Mexico, and 14 previous novel CoVs have been recorded in Mexican bats.

COVID‐19 is a highly contagious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2). It has rapidly spread to 216 countries and territories since first outbreak in December of 2019, posing a substantial economic losses and extraordinary threats to the public health worldwide. Although bats have been suggested as the natural host of SARS‐CoV‐2, transmission chains of this virus, role of animals during cross‐species transmission, and future concerns remain unclear.

During the first wave of COVID‐19 in China, the attack rate of coronavirus disease 2019 (COVID‐19) in children was much lower than in adults, and most child cases had mild symptoms (Dong et al 2020). However, the secondary attack rate of COVID‐19 among close contacts was later found similar between children and other age groups (Bi et al). In Wuhan, Hubei province, China, there was only one paediatric case of COVID‐19 officially reported before January 22, 2020.

There is growing evidence that climatic factors could influence the evolution of the current COVID‐19 pandemic. Here, we build on this evidence base, focusing on the southern hemisphere summer and autumn period. The relationship between climatic factors and COVID‐19 cases in New South Wales, Australia was investigated during both the exponential and declining phases of the epidemic in 2020, and in different regions.

Pets from COVID‐19 owners were screened for SARS‐CoV‐2 (April‐May 2020). From 23 pets, an asymptomatic cat showed positive RT‐qPCRs results from oropharyngeal swab (negative rectal swab). Remaining pets were negative. This suggests that cats can contract the virus from their infected owners and may act as potential hosts for SARS‐CoV‐2. Their role in carrying live or infectious viruses and disseminating them needs more investigation.

The outbreak of COVID‐19 as a pandemic has shaken the global health system and economy by their roots. This epidemic is still spreading and showing no signs of decreasing trend. Vaccination could be the only effective and economical means to control this pandemic. A number of research institutions and pharmaceutical companies have plunged into the race of vaccine development against COVID‐19 which are in various stages of development.

Coronavirus disease 2019 (COVID‐19) caused by severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) has become a global pandemic. Therefore, convenient, timely and accurate detection of SARS‐CoV‐2 is urgently needed. Here, we review the types, characteristics and shortcomings of various detection methods, as well as perspectives for the SARS‐CoV‐2 diagnosis. Clinically, nucleic acid‐based methods are sensitive but prone to false‐positive.

Pre‐clinical responses to fast‐moving infectious disease outbreaks heavily depend on choosing the best isolates for animal models that inform diagnostics, vaccines and treatments. Current approaches are driven by practical considerations (e.g. first available virus isolate) rather than a detailed analysis of the characteristics of the virus strain chosen, which can lead to animal models that are not representative of the circulating or emerging clusters.

Coronavirus disease 2019 (COVID‐19) is an emerging infectious disease first identified in Wuhan City, Hubei Province, China. As of 19 February 2020, there had been 333 confirmed cases reported in Shanghai, China. This study elaborates on the epidemiological and clinical characteristics of COVID‐19 based on a descriptive study of the 333 patients infected with COVID‐19 in Shanghai for the purpose of probing into this new disease and providing reference.

Repurposing of existing anti‐viral drugs, immunological modulators and supportive therapies represents a promising path towards rapidly developing new control strategies to mitigate the devastating public health consequences of the COVID‐19 pandemic.